Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Julie Stern, MPH

Kaiser Permanente Southern California

Disclosure(s): GlaxoSmithKline: Grant/Research Support; Pfizer: Grant/Research Support; Sanofi: Grant/Research Support

Poster(s):

(P-56) Respiratory Syncytial Virus (RSV) Vaccine Uptake among Adults ≥60 years old in a Large Integrated Healthcare System in the U.S.

Thursday, October 17, 2024
12:15 PM – 1:30 PM US PT
(P-604) Preliminary real-world Abrysvo vaccine effectiveness (VE) against Respiratory Syncytial Virus (RSV)-related lower respiratory tract disease (LRTD) hospitalizations and emergency department (ED) visits—Kaiser Permanente of Southern California (KPSC), November 2023-April 2024

Thursday, October 17, 2024
12:15 PM – 1:30 PM US PT